ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 414 filers reported holding ENCOMPASS HEALTH CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,207 | -8.1% | 5,825 | -7.3% | 0.00% | -50.0% |
| Q2 2023 | $425,597 | -47.5% | 6,286 | -58.1% | 0.00% | 0.0% |
| Q1 2023 | $811,013 | -10.6% | 14,991 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $907,378 | +27.1% | 15,171 | -3.9% | 0.00% | 0.0% |
| Q3 2022 | $714,000 | -19.6% | 15,784 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $888,000 | -25.3% | 15,836 | -5.3% | 0.00% | -33.3% |
| Q1 2022 | $1,189,000 | +6.5% | 16,724 | -2.2% | 0.00% | +50.0% |
| Q4 2021 | $1,116,000 | +294.3% | 17,096 | +394.1% | 0.00% | +100.0% |
| Q1 2021 | $283,000 | -6.3% | 3,460 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $302,000 | +15.3% | 3,649 | -9.6% | 0.00% | 0.0% |
| Q3 2020 | $262,000 | -6.4% | 4,035 | +12.5% | 0.00% | 0.0% |
| Q3 2018 | $280,000 | +7.3% | 3,587 | -6.9% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | – | 3,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |